Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alejandro Sosa Espinoza"'
Autor:
Ulises Zendejas-Hernandez, Nemi Alcántara-Martínez, Diana Tovar Vivar, Fermín Valenzuela, Alejandro Sosa Espinoza, Eduardo Emir Cervera Ceballos
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
IntroductionGlycyrrhizin (GA) and its derivative Enoxolone (18β), isolated from the Glycyrrhiza glabra plant, are two potential molecules for treating viral diseases. Both demonstrate to regulate immune system with antiviral and anti-inflammatory ac
Externí odkaz:
https://doaj.org/article/dace8543334a4a10bb288be1c5756c5c
Autor:
Juan Antonio Flores-Jiménez, Ruben Solis-Armenta, Guillermo Diaz-Vargas, Eleazar Hernández-Ruiz, Eduardo Cervera, Javier de Jesús Morales-Adrián, Esperanza Barrera, Juan Carlos Solís-Poblano, Oscar Perez, José Luis Álvarez-Vera, Miguel Herrera, Ramiro Espinoza-Zamora, Álvaro Cabrera-García, Eugenia Espitia-Rios, Manuel Solano Manuel, Esthela Juan Lien-Chang Lourdes, Juan Ojeda-Tovar, Juan Manuel Pérez Zúñiga, David Gómez-Almaguer, Cristian Ramos-Penafiel, Alejandro Sosa-Espinoza, Jose Antonio De la Pena, Adrián A. Ceballos-López, Roberta Demichelis, Javier Mijangos, Eva Fabiola Ramirez-Romero, Nidia Zapata-Canto, Martha Alvarado-Ibarra, Manuel Aguilar, Victor Antonio Guillermo, Gladys Gomez-Perdomo, Efren Montano, Luara Arana
Publikováno v:
Journal of Hematology
Background: The present retrospective study reviewed acute promyelocytic leukemia (APL) cases recorded in Mexico between January 2007 and January 2017. The primary objective of the study was to evaluate overall survival (OS) in Mexican patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46190f1464790d5be642b0374eba96d4
https://doi.org/10.14740/jh773
https://doi.org/10.14740/jh773
Autor:
Alejandro Sosa-Espinoza, Nidia Zapata-Canto, Jorge Torres-Flores, Eduardo Cervera-Ceballos, Jorge Garcia-Mendez, Ramiro Espinoza-Zamora
Publikováno v:
Journal of Hematology
Background: The main causes of mortality in patients with acute leukemia are the infectious complications. The author wanted to know the induction-related mortality and treatment-related mortality in the acute leukemia patients at the Instituto Nacio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae02dc2d0c96b1d8c2b304774a77cb5
https://doi.org/10.14740/jh751
https://doi.org/10.14740/jh751
Autor:
Juan Rafael Labardini-Méndez, Eduardo Cervera, Alfonso Dueñas-González, Myrna Candelaria, Jose Ramiro Espinoza-Zamora, Nidia Zapata-Canto, Alejandro Sosa-Espinoza, Magnolia Vieyra-García, Celia López-González, Valentin Lozano-Zavaleta, Diana Vanesa Toledano-Cuevas
Publikováno v:
Expert Opinion on Investigational Drugs. 26:481-487
Objectives To evaluate the activity and safety of hydralazine and valproate (Transkrip) in cutaneous T-cell lymphoma (CTCL). Methods Previously untreated and progressive/refractory CTCL patients received hydralazine at 83 mg or 182 mg/day for slow an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b3f7a16aa954f64ce97a100d886b7e
https://doi.org/10.1080/13543784.2017.1291630
https://doi.org/10.1080/13543784.2017.1291630